• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problems Activation, Positioning or Separation Problem (2906); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/25/2022
Event Type  malfunction  
Event Description
It was reported that the stent partially deployed and stretched.The target lesion was located in the superficial femoral artery (sfa).A 7x120, 130cm eluvia drug-eluting vascular stent system was selected for an endovascular therapy (evt) procedure.The lesion was predilated.During the procedure, the thumbwheel was completely rotated; however, the stent did not fully deploy.There was a grinding tone when the thumbwheel was being rotated.When the entire delivery shaft was pulled, the stent deployed and stretched approximately 3cm.There were no patient complications.
 
Event Description
It was reported that the stent partially deployed and stretched.The target lesion was located in the superficial femoral artery (sfa).A 7x120, 130cm eluvia drug-eluting vascular stent system was selected for an endovascular therapy (evt) procedure.The lesion was predilated.During the procedure, the thumbwheel was completely rotated; however, the stent did not fully deploy.There was a grinding tone when the thumbwheel was being rotated.When the entire delivery shaft was pulled, the stent deployed and stretched approximately 3cm.There were no patient complications.
 
Manufacturer Narrative
Device evaluated by mfr: the returned product consisted of an eluvia self-expanding stent system with a flimsy 0.035 inch hydrophilic guidewire stuck inside.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed a kink to the outer sheath at the nosecone.Microscopic examination revealed no additional damages.The handle was disassembled, and the proximal inner is prolapsed.The stent appears to have been deployed and did not return for analysis.Inspection of the remainder of the device, revealed no other damage or irregularities.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key14459870
MDR Text Key292371923
Report Number2134265-2022-05660
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/26/2023
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0028059665
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/18/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/25/2022
Initial Date FDA Received05/20/2022
Supplement Dates Manufacturer Received05/26/2022
Supplement Dates FDA Received06/17/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/26/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-